| Date | Form | Description | Docs | XBRL | Pages |
| 10/03/06 | DEF 14A | Definitive proxy statements |
|
17 | |
| 09/11/06 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
30 | |
| 07/20/06 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/16/06 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 06/09/06 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
27 | |
| 06/05/06 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/05/06 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/05/06 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 03/17/06 | S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans |
|
13 | |
| 03/10/06 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
|
28 |
Latest News & Events
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Read More...Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...